-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

113. Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science: Poster II

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Jaira F. de Vasconcellos*, Y. Terry Lee*, Colleen Byrnes, MS*, Laxminath Tumburu*, Antoinette Rabel* and Jeffery L. Miller, MD

Molecular Genomics and Therapeutics Section, Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

Margaret F. Bennewitz, PhD1, Ravi Vats, MS1*, Egemen Tutuncuoglu, MS1*, Mark T. Gladwin, MD1,2 and Prithu Sundd, PhD1,2,3

1Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
2Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA
3Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA

Patricia A Shi, MD1, Erika Choi, BA1*, Julia Nguyen, BS2*, Xinhua Guo, BS3*, Narla Mohandas, DSc1, Abdu Alayash, PhD4*, Elizabeth Manci, MD5, John D. Belcher, PhD6 and Gregory M Vercellotti6

1New York Blood Center, New York, NY
2Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
3Red Cell Physiology Laboratory, New York Blood Center, New York, NY
4FDA, CBER, Silver Spring, MD
5University of South Alabama Health System, Mobile, AL
6Department of Medicine, Vascular Biology Center, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Marcus A Carden, MD1,2*, Meredith Ellen Fay, BS2*, Yumiko Sakurai, MSc1,2*, Robert G Mannino, BS1,2*, Jordan Ciciliano, BS3*, Reginald Tran, BS2* and Wilbur A Lam, MD, PhD1,2

1Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA
2Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
3Woodruff School of Mechanical Engineering, Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA

Beverly A Schaefer, MD1, Jonathan M Flanagan, PhD2, Thad A. Howard, MS1*, Kerri A Nottage, MD, MPH3, Connie M. Piccone, MD4, Scott T. Miller, MD5, Alex George, M.D., Ph.D.2, Beatrice E. Gee, M.D.6, Barry R Davis, MD PhD7* and Russell E. Ware, MD, PhD1

1Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Baylor College of Medicine, Houston, TX
3St. Jude Children's Research Hospital, Memphis, TN
4Case Western Reserve University, Cleveland, OH
5SUNY Downstate, Brooklyn, NY
6Morehouse School of Medicine, Atlanta, GA
7University of Texas School of Public Health, Houston, TX

Daniel Gil de Lamadrid1,2, Yaritza Inostroza-Nieves2,3*, Joshua Cazares1,2*, Isamar Alicea1,2,3*, Analaura Santiago1,2,4*, Shirley Valentin1,4*, Jose R Romero2* and Alicia Rivera1

1Department of Laboratory Medicine, Boston Childen's Hospital and Department of Pathology, Harvard Medical School, Boston, MA
2Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA
3Department of Biochemistry and Pharmacology, San Juan Bautista School Of Medicine, Caguas, PR
4Department of Microbiology, San Juan Bautista School Of Medicine, Caguas, PR

Pradeep K Dagur, PhD1*, J. Philip McCoy, PhD2, J Nichols3*, Laurel Mendelsohn, BS4*, C Seamon3*, Gregory J Kato, MD5* and Eduard J van Beers, MD, PhD6*

1Flow Cytometry Core Facility, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
2Flow Cytometry Core Facility, National Heart, Lung, and Blood Institute, Bethesda, MD
3Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
4Sickle Cell Vascular Disease Section, Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD
5Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA
6Van Creveldkliniek, center for benign hematology, University Medical Centre, Utrecht, Netherlands

Paula L Croal, PhD1*, Malambing G Serafin1*, Przemyslaw Kosinski, BSc2,3*, Jackie Leung, MASc1*, Suzan Williams, MD4 and Andrea Kassner, PhD1,5*

1Peter Gilgan Centre for Learning and Research, Physiology & Experimental Medicine, The Hospital for Sick Children, Toronto, ON, Canada
2Institute of Medical Science, University of Toronto, Toronto, ON, Canada
3Peter Gilgan Centre for Research and Learning, Physiology & Experimental Medicine, The Hospital for Sick Children, Toronto, ON, Canada
4Division of Hematology, The Hospital for Sick Children, Toronto, ON, Canada
5Medical Imaging, University of Toronto, Toronto, ON, Canada

Ying Wang, MD, PhD*, Jianxun Lei, PhD*, Yann Y Lamarre, PhD*, Ritu Jha, M.sc*, Fei Peng, M.sc*, Sarah Lam*, Ellis Raduenz*, Deniz Ercan-Fang* and Kalpna Gupta, PhD

Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN

Richard J Kulmacz, PhD1*, Wen Liu, PhD2*, Vladimir Berka, PhD1*, Mohammad H. Rahbar, PhD3*, Modupe Idowu, MD1, Alex George, M.D., Ph.D.4 and Harinder S. Juneja, MD1

1Department of Internal Medicine-Hematology Division, University of Texas Health Science Center at Houston, Houston, TX
2Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX
3Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX
4Hematology Center, Texas Children's Hospital, Houston, TX

Chia-Hao Liu, PhD1*, Olusola Laja, BA, MSc2*, Laurel Mendelsohn, BS3*, Kathleen Vaughan, BA4*, Lena Diaw, PhD5*, Jefferey Kopp, MD6* and James G. Taylor, M.D.7

1NHLBI/NIH, Bethesda, MD
2Meharry Medical College, Nashville, TN
3Sickle Cell Vascular Disease Section, Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD
4Genomic Medicine Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
5NIH/NHLBI, Bethesda, MD
6NIDDK/NIH, Bethesda
7NHLBI, National Institutes of Health, Bethesda, MD, Bethesda

Athiwat Hutchaleelaha, Ph.D.*, Mira Patel, PhD*, Abel Silva*, Donna Oksenberg, PhD* and Brian Metcalf, Ph.D.*

Global Blood Therapeutics, South San Francisco, CA

Marina Pereira Colella, MD, PhD1*, Barbara Santana, PhD2*, Rodrigo T. Calado, MD, PhD3 and Sara T Saad, M.D., PhD1

1Hematology and Hemotherapy Center, University of Campinas, UNICAMP , INCT do Sangue, Campinas, Brazil
2Department of Internal Medicine, University of São Paulo at Ribeirão Preto Medical School, Ribeirao Preto, Brazil
3Department of Internal Medicine, University of São Paulo at Ribeirão Preto Medical School, Ribeirão Preto, Brazil

Barbara Sandor1*, Mickael Marin2*, Claudine Lapoumeroulie2*, Miklos Rabai1*, Sophie Lefevre2*, Nathalie Lemonne3*, Wassim El Nemer2*, Olivier Francais4*, Bruno Le Pioufle4*, Yves Colin Aronovicz2, Philippe Connes, PhD5* and Caroline Le Van Kim2*

1Department of Medicine, University of Pecs Medical School, Pecs, Hungary, Pecs, Hungary
2UMR_S1134, University Paris Diderot/Inserm/INTS, Paris, France
3Unité Transversale de la Drépanocytose, CHU de Pointe-à-Pitre, Guadeloupe, Pointe à Pitre, France
4SATIE, ENS Cachan/CNRS/UMR8029, Paris, France
5Center of Research and Innovation in Sports, Université Claude Bernard Lyon 1, Villeurbanne, France

*signifies non-member of ASH